BNIP3 and metabolic dysfunction-associated steatotic liver disease: Furthermore, for non-alcoholic fatty liver disease, SIRT3 overexpression can protect liver cells by promoting BNIP3-mediated-mitophagy and reducing mitochondrial apoptosis, thus effectively treating non-alcoholic cirrhosis (Li et al., 2018).